Literature DB >> 2791332

Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease.

M Eto1, K Watanabe, I Makino.   

Abstract

It has been demonstrated that the genetic polymorphism of apolipoprotein (apo) E is associated with atherosclerosis. Thus, in this study, we have examined the apo E allele frequencies in 109 patients with ischemic heart disease (IHD) and 576 Japanese people as controls, and we have compared these frequencies between patients with IHD and controls. The frequencies of the epsilon 2 and epsilon 4 alleles were significantly higher in patients with IHD than in the controls (epsilon 2: 8.2% vs 3.7%, epsilon 4: 17.0% vs 11.7%), whereas the frequency of the epsilon 3 allele was significantly lower in patients with IHD than in the controls (74.8% vs 84.6%). The epsilon 2-carrying patients with IHD were characterized by type III (43.8%) and IV (25.0%) hyperlipoproteinemia (HLP), whereas the epsilon 4-carrying patients with IHD were characterized by hypercholesterolemia (type IIb HLP: 42.8%, type IIa HLP: 28.6%). It is concluded that both epsilon 2 and epsilon 4 alleles are more associated with IHD than the epsilon 3 allele.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791332     DOI: 10.1111/j.1399-0004.1989.tb03186.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  ApoE isoforms, treatment of diabetes and the risk of coronary heart disease.

Authors:  Hideki Ehara; Ritsuko Yamamoto-Honda; Hiroji Kitazato; Yoshihiko Takahashi; Shoji Kawazu; Yasuo Akanuma; Mitsuhiko Noda
Journal:  World J Diabetes       Date:  2012-03-15

2.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

3.  Frequencies and Distribution of APOE Gene Polymorphisms and Its Association With Lipid Parameters in the Senegalese Population.

Authors:  Maïmouna Touré; Niokhor N Diouf; Souleymane Thiam; Jean P Diop; Mame S Coly; Arame Mbengue; Fatou B Sar; Abdoulaye Ba; Fatou A Diallo; Abdoulaye Samb
Journal:  Cureus       Date:  2022-04-12

4.  APOE Variants E2, E3, and E4 Can Be Miscalled By Classical PCR-RFLP When The Christchurch Variant Is Also Present.

Authors:  Beatriz Candás-Estébanez; Ariadna Padró-Miquel; Cristina Ruiz-Iruela; Emili Corbella-Inglés; Xavier Pintó-Sala; Pedro Alía-Ramos
Journal:  J Clin Lab Anal       Date:  2016-08-27       Impact factor: 2.352

5.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Authors:  C R Harrington; J Louwagie; R Rossau; E Vanmechelen; R H Perry; E K Perry; J H Xuereb; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

6.  Apolipoprotein E4 polymorphism as risk factor for coronary heart disease among Indian subjects.

Authors:  Tester F Ashavaid; Seema P Todur; Kappiareth G Nair
Journal:  Indian J Clin Biochem       Date:  2002-01

7.  Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma.

Authors:  T Y M Lo; P A Jones; I R Chambers; T F Beattie; R Forsyth; A D Mendelow; R A Minns
Journal:  Childs Nerv Syst       Date:  2008-10-07       Impact factor: 1.475

8.  Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.

Authors:  Taranjit Singh Rai; Madhu Khullar; B S Sehrawat; Monica Ahuja; Praveen Kumar Sharma; Rajesh Vijayvergiya; Anil Grover
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

Review 9.  Newer perspectives of coronary artery disease in young.

Authors:  Amitesh Aggarwal; Saurabh Srivastava; M Velmurugan
Journal:  World J Cardiol       Date:  2016-12-26

10.  Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+.

Authors:  Sari Rastas; Kimmo Mattila; Auli Verkkoniemi; Leena Niinistö; Kati Juva; Raimo Sulkava; Esko Länsimies
Journal:  BMC Geriatr       Date:  2004-03-29       Impact factor: 3.921

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.